Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein

被引:78
|
作者
Rothenburger, M
Markewitz, A
Lenz, T
Kaulbach, HG
Marohl, K
Kuhlmann, WD
Weinhold, C
机构
[1] Cent Mil Hosp, Dept Cardiovasc Surg, Koblenz, Germany
[2] Cent Mil Hosp, Dept Anesthesiol, Koblenz, Germany
[3] Cent Lab Inst, Koblenz, Germany
关键词
procalcitonin; C-reactive protein; cardiac surgery; major surgical trauma; cardiopulmonary bypass infection; acute phase response;
D O I
10.1515/CCLM.1999.048
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: Established parameters, e.g. C-reactive protein (CRP), do not differentiate specifically enough between patients developing an infection and those exhibiting an acute phase response following cardiac surgery. The objective of this prospective study was to investigate if procalcitonin (PCT) ist more helpful than CRP. Methods: During a 1-year period, seven out of 563 patients (1.2 %) developed systemic infections (group A) after cardiac operations with cardiopulmonary bypass (CPB), and additional eight patients (1.4%) had local wound infections requiring surgical therapy (group B). Blood samples for PCT and CRP measurements were taken preoperatively, at the onset of infection (d1), as well as on the third day (d3), fifth day (d5), and seventh day (d7) following diagnosis of infection. Forty-four randomly selected patients undergoing cardiac surgery with CPB without clinical signs of infection, additional intensive care unit (ICU) management or additional antibiotic treatment served as control (group C) to assess the PCT and CRP contribution to acute phase response. PCT and CRP levels were measured preoperatively, on the first (dl), third (d3) and fifth day (d5) after operation. Results: At the onset of infection, PCT levels (median interquartile range 25%-75%) increased significantly in group A as compared to baseline values (10.86 (3.28-15.13) ng/ml vs. 0.12 (0.08-0.21) ng/ml), and decreased during treatment to still significantly elevated values on d5 (0.56 (0.51-0.85)ng/ml). CRP levels were significantly elevated on all days investigated with no trend towards normalisation (dl: 164.5 (137-223) mg/l) vs. 1.95 (1.1-2.8) mg/l preoperatively, d5: 181.1 (134-189.6) mg/l. In group B, no increase in PCT levels, but a significant increase of CRP from dl (165.9 (96.6-181.6) mg/l vs. 3.7 (2-4.3) mg/l preopratively) until d5 98 (92.8-226.2) mg/l was detected. In group C, postoperative PCT levels increased slightly but significantly in the absence of infection on dl (0.46 (0.26-0.77) ng/ml vs. 0.13 (0.08-0.19) ng/ml preoperatively, and d3 (0.37 (0.2-0.65)ng/ml and reached baseline on d5 (0.24 (0.11-0.51) ng/ml)). CRP levels were significantly elevated as compared to baseline on all postoperative days investigated (baseline: 1.75 (0.6-2.9) mg/l, dl: 97.5 (74.5-120) mg/l), d3: 114(83.05-168.5) mg/l, d5: 51.4 (27.4-99.8) mg/l)). PCT showed a significant correlation to CRP in group A (r = 0.48, p<0.001), a weak correlation in group C (r = 0.27, p = 0.002) and no correlation in group B. Intergroup comparison revealed a significant difference for PCT between all groups (A>C>B) and significantly higher CRP levels in group A vs. C and in group B vs. C. Thus, the pattern high PCT/high CRP appears to indicate a systemic infection, while low PCT/high CRP indicates either acute phase response or local wound problems but no systemic infection. The cost for PCT measurements was 5.6-fold higher as compared to CRP. Conclusion: Due to the significant differences in the degree of increase, PCT appears to be useful in discriminating between acute phase response following cardiac surgery with CPB or local problems and systemic infections, with additional CRP-measurement increasing the specifity.
引用
收藏
页码:275 / 279
页数:5
相关论文
共 50 条
  • [41] Prognostic biomarkers in acute exacerbation of COPD:: copeptin, C-reactive protein and procalcitonin
    Stolz, D.
    Christ-Crain, M.
    Morgenthaler, N.
    Leuppi, J.
    Miedinger, D.
    Bingisser, R.
    Mueller, C.
    Mueller, B.
    Tamm, M.
    SWISS MEDICAL WEEKLY, 2007, 137 : 15S - 15S
  • [42] ACUTE PHASE PROTEINS IN NEONATAL RABBITS - DIMINISHED C-REACTIVE PROTEIN RESPONSE
    BAKER, RD
    LONG, S
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1990, 11 (04): : 534 - 541
  • [43] Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD
    Stolz, Daiana
    Christ-Crain, Mirjam
    Morgenthaler, Nils G.
    Leuppi, Joerg
    Miedinger, David
    Bingisser, Roland
    Mueller, Christian
    Struck, Joachim
    Mueller, Beat
    Tamm, Michael
    CHEST, 2007, 131 (04) : 1058 - 1067
  • [44] LIPOPROTEINS AND ACUTE PHASE RESPONSE DURING ACUTE INFECTION - INTERRELATIONSHIPS BETWEEN C-REACTIVE PROTEIN AND SERUM AMYLOID-A PROTEIN AND LIPOPROTEINS
    SAMMALKORPI, KT
    VALTONEN, VV
    MAURY, CPJ
    ANNALS OF MEDICINE, 1990, 22 (06) : 397 - 401
  • [45] Role of C-Reactive Protein at Sites of Inflammation and Infection
    Sproston, Nicola R.
    Ashworth, Jason J.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [46] DETECTION OF SERUM PROCALCITONIN AND HYPERSENSITIVE C-REACTIVE PROTEIN IN PATIENTS WITH PNEUMONIA AND SEPSIS
    Liu, G. B.
    Cui, X. Q.
    Wang, Z. B.
    Wen, L.
    Duan, H. L.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (05): : 1165 - 1169
  • [47] DETECTION OF COMBINED PROCALCITONIN AND C-REACTIVE PROTEIN APPLIED IN THE DIAGNOSIS OF BACTERIAL INFECTIONS
    Li, Y. L.
    Zhai, L. C.
    Ji, J. H.
    Liu, L. Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2017, 31 (01): : 177 - 181
  • [48] The role of C-reactive protein in the resolution of bacterial infection
    Du Clos, TW
    Mold, C
    CURRENT OPINION IN INFECTIOUS DISEASES, 2001, 14 (03) : 289 - 293
  • [49] Clinical significance of the detection of procalcitonin and C-reactive protein in the intensive care unit
    Li, Qinhao
    Gong, Xiaona
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (05) : 4265 - 4270
  • [50] STUDIES ON HUMAN ACUTE PHASE PROTEIN (C-REACTIVE PROTEIN)
    BRATTSTEN, I
    HEDLUND, P
    ACTA CHEMICA SCANDINAVICA, 1956, 10 (01): : 151 - 152